BIGGIOGGERO, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 768
EU - Europa 367
AS - Asia 259
SA - Sud America 21
OC - Oceania 20
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.456
Nazione #
US - Stati Uniti d'America 709
IT - Italia 106
CN - Cina 93
DE - Germania 73
GB - Regno Unito 44
IN - India 38
FR - Francia 36
NL - Olanda 31
MX - Messico 29
CA - Canada 22
JP - Giappone 19
TW - Taiwan 19
AU - Australia 16
ES - Italia 15
IR - Iran 14
KR - Corea 13
ID - Indonesia 12
IE - Irlanda 11
BR - Brasile 9
CZ - Repubblica Ceca 9
TH - Thailandia 9
ZA - Sudafrica 9
PH - Filippine 7
SG - Singapore 7
TR - Turchia 7
PR - Porto Rico 6
RS - Serbia 6
CL - Cile 5
CH - Svizzera 4
CO - Colombia 4
DK - Danimarca 4
FI - Finlandia 4
HK - Hong Kong 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
BG - Bulgaria 3
NO - Norvegia 3
SE - Svezia 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AP - ???statistics.table.value.countryCode.AP??? 2
AR - Argentina 2
BE - Belgio 2
EG - Egitto 2
GR - Grecia 2
GT - Guatemala 2
KE - Kenya 2
RO - Romania 2
RU - Federazione Russa 2
AT - Austria 1
BD - Bangladesh 1
CM - Camerun 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
EU - Europa 1
IQ - Iraq 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
NG - Nigeria 1
PL - Polonia 1
PT - Portogallo 1
TN - Tunisia 1
VN - Vietnam 1
YE - Yemen 1
Totale 1.456
Città #
Milan 57
Ashburn 47
Storm Lake 47
Fairfield 46
Beijing 43
Santa Cruz 36
Houston 35
Seattle 31
Woodbridge 25
San Diego 22
Buffalo 21
Chicago 15
Wilmington 14
Ann Arbor 12
Des Moines 11
Dublin 10
Cambridge 9
Jakarta 9
Shanghai 9
Toronto 9
Bologna 8
Edinburgh 7
Las Vegas 7
Dearborn 6
Menlo Park 6
New York 6
San Juan 6
Singapore 6
Sydney 6
Taipei 6
Tokyo 6
Belgrade 5
Delhi 5
Esslingen am Neckar 5
Los Angeles 5
Mumbai 5
Redmond 5
Annecy 4
Boardman 4
Council Bluffs 4
Cuajimalpa 4
Helsinki 4
Nanjing 4
New Delhi 4
Paris 4
Seoul 4
Southend 4
University Park 4
Wuhan 4
Bangalore 3
Bengaluru 3
Bergkirchen 3
Cape Town 3
Chennai 3
Cincinnati 3
Clearwater 3
Medellín 3
Melbourne 3
Oviedo 3
San Francisco 3
San Jose 3
Santiago 3
Torino 3
Amsterdam 2
Atlanta 2
Auburn University 2
Brisbane 2
Burlington 2
Chengdu 2
Cleveland 2
Columbia 2
Copenhagen 2
Den Haag 2
Dongguan 2
Durgapur 2
Florence 2
Frankfurt am Main 2
Grafing 2
Grassobbio 2
Greenville 2
Grenoble 2
Guatemala City 2
Hangzhou 2
Henderson 2
Jerez De La Frontera 2
Kansas City 2
Karachi 2
Khon Kaen 2
Kolkata 2
Kwai Chung 2
Llanelli 2
Maastricht 2
Madrid 2
Manisa 2
Marburg 2
Mexico 2
Mountain View 2
Nairobi 2
Nocera Inferiore 2
Nuremberg 2
Totale 772
Nome #
Baricitinib for COVID-19: a suitable treatment?, file dfa8b9a2-9be1-748b-e053-3a05fe0a3a96 465
Eight-year retention rate of first-line tumor necrosis factor inhibitors in spondyloarthritis : A multi-center retrospective analysis, file dfa8b996-b69e-748b-e053-3a05fe0a3a96 340
Role of antimalarials in COVID-19 : observational data from a cohort of rheumatic patients, file dfa8b9a3-4742-748b-e053-3a05fe0a3a96 124
Transforming growth factor beta1 in the pathogenesis of autoimmune congenital complete heart block : lesson from twins and triplets discordant for the disease, file dfa8b990-f5c1-748b-e053-3a05fe0a3a96 97
IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors, file dfa8b9a1-56c3-748b-e053-3a05fe0a3a96 92
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic, file dfa8b9a9-e64b-748b-e053-3a05fe0a3a96 85
Tocilizumab in the treatment of rheumatoid arthritis : An evidence-based review and patient selection, file dfa8b9a9-8412-748b-e053-3a05fe0a3a96 49
Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis, file dfa8b9a9-af85-748b-e053-3a05fe0a3a96 43
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis : Evidence to date, file dfa8b9a9-9a31-748b-e053-3a05fe0a3a96 35
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations, file d14f0203-170d-4e76-a724-a85bb7aa85d6 30
Sarilumab : patient-reported outcomes in rheumatoid arthritis, file dfa8b9a9-b6bc-748b-e053-3a05fe0a3a96 26
The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept : Retrospective analysis of a local registry, file dfa8b9a9-9a39-748b-e053-3a05fe0a3a96 22
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: Focus on interchangeability, file 00d3bacc-0d1b-45d7-97fa-173a4e2e337f 18
The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors, file dfa8b9a9-825a-748b-e053-3a05fe0a3a96 18
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study, file 63321e07-d081-468f-8937-4771c9f30d2a 16
The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry, file dfa8b9aa-6981-748b-e053-3a05fe0a3a96 14
The challenging definition of naïve patient for biological drug use, file dfa8b992-420c-748b-e053-3a05fe0a3a96 11
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study, file 40799a67-ffad-45a3-859a-850af4544438 9
Structural integrity versus radiographic progression in rheumatoid arthritis, file 9be45dbd-9b37-4901-835e-23492b8e2b45 5
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients : Results from the GISEA register, file dfa8b99e-3df6-748b-e053-3a05fe0a3a96 4
The management of first-line biologic therapy failures in rheumatoid arthritis : current practice and future perspectives, file dfa8b99f-3cef-748b-e053-3a05fe0a3a96 4
Comment on : Bisphosphonates and osteonecrosis of the jaw, file dfa8b990-f4cc-748b-e053-3a05fe0a3a96 3
The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrolment: data from a systematic review and meta-analysis, file dfa8b990-fa64-748b-e053-3a05fe0a3a96 3
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations : similarities and differences, file dfa8b9a9-9aa6-748b-e053-3a05fe0a3a96 3
Sex and Management of Rheumatoid Arthritis, file dfa8b9a9-abba-748b-e053-3a05fe0a3a96 2
Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights, file 0f623f14-5f86-4827-bed5-d63a633f114e 1
Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis, file af41ddb0-f771-4243-b357-4f98e046f729 1
Cutting-Edge Issues in Coronary Disease and the Primary Antiphospholipid Syndrome, file dfa8b990-98bf-748b-e053-3a05fe0a3a96 1
Osteoporosis, file dfa8b990-f069-748b-e053-3a05fe0a3a96 1
null, file dfa8b990-f3fa-748b-e053-3a05fe0a3a96 1
Is there really room for anti-rheumatic drugs in the treatment of COVID-19?, file dfa8b9a3-151d-748b-e053-3a05fe0a3a96 1
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab : results from the Italian GISEA registry, file dfa8b9a9-e343-748b-e053-3a05fe0a3a96 1
Totale 1.525
Categoria #
all - tutte 3.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201925 0 0 0 0 0 0 0 0 0 2 13 10
2019/202073 5 7 4 11 6 11 2 6 7 8 3 3
2020/2021193 7 17 8 12 16 23 28 19 14 20 12 17
2021/2022597 38 42 98 67 41 22 48 52 44 27 81 37
2022/2023350 20 11 66 76 16 37 24 17 10 24 40 9
2023/2024231 25 11 21 21 27 21 24 43 27 11 0 0
Totale 1.525